Kevin Labadie, MD
I am originally from California, born and raised in the San Francisco bay area. I love to stay active: skiing in the winter, mountain biking and hiking in the summer. There are few places better to do all of these things than Seattle. I recently completed two years of research conducting translational research in oncology advancing therapies for solid gastrointestinal tumors. I am interested in being an academic surgical oncologist.
Skiing, mountain biking, hiking, reading, Seinfeld
Surgical oncology, gastrointestinal surgery, minimally invasive surgery
UW GME Policy Committee
I chose to join the UW Department of Surgery because of the broad and complex clinical exposure (tertiary university and county hospital, VA, pediatric and community hospital experience), the academic/research opportunities and the impressive faculty and residents. In addition, Seattle is a truly wonderful place to live and train to be a surgical resident.
What advice do you have for incoming interns?
Work hard, play hard, learn always.
What do you like best about living in Seattle?
There are many things I like about Seattle: it is a laid back, cosmopolitan city with great food and culture. Most importantly to me, it has great access to the outdoors, to the mountains and the water. The weather is mild year round and manageable. Summers are beautiful and winters are not bad (particularly if you like to ski or do other snow sports!).
- Okhunov Z, Del junco M, Yoon R, Labadie K, Lusch A, Ordon M. In vitro evaluation of LithAssist: a novel combined holmium laser and suction device. J Endourol. 2014;28(8):980-4. [original work]
- Labadie K, Okhunov Z, Akhavein A, et al. Evaluation and comparison of urolithiasis scoring systems used in percutaneous kidney stone surgery. J Urol. 2015;193(1):154-9. [original work]
- Tailly TO, Okhunov Z, Nadeau BR, Labadie KP et al. Multicenter External Validation and Comparison of Stone Scoring Systems in Predicting Outcomes After Percutaneous Nephrolithotomy. J Endourol. 2016;30(5):594-601. [original work]
- Veran-Taguibao S, Labadie KP, Lin F, et al. Aggressive Thyroid Carcinoma Mimicking a Benign Histiocytic Proliferation-Utility of Tumor Markers by Immunohistochemical Analysis. Cancer Res Rep. 2018; 1: 101. [original work]
- Daniel SK, Sullivan KM, Labadie KP, Pillarisetty VG. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma. Clin Transl Med. 2019;8(1):10. [review]
- Labadie KP, Schaub SK, Khorsand D, Johnson G, Apisarnthanarax S, Park JO. Multidisciplinary approach for multifocal, bilobar hepatocellular carcinoma: A case report and literature review. World J Hepatol. 2019;11(1):119-126. [review]
- Ludwig AD, Labadie KP, Seo YD, et al. Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma. J Oncol. 2019; 2019:4564707. [original work]
- Brempelis KJ, Cowan CM, Kreuser SA, Labadie KP, et al. Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses. J Immunother Cancer. 2020;8(2). [original article]
- Labadie KP, Ludwig AD, Lehnert AL, et al. Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma. Sci Rep. 2021;11(1):3731. [original article]
- Labadie, K.P., Droullard, D.J., Lois, A.W. et al. IWATE criteria are associated with perioperative outcomes in robotic hepatectomy: a retrospective review of 225 resections. Surg Endosc (2021). [original article]
- Labadie KP, Sullivan KM, Daniel SK, Park JO, Yeung RS. Liver surgery- less is more. Laparoscop Surg 2019; 3:19. [Invited editorial]
- Labadie KP, Sham JG. Adjuvant transcatheter arterial infusion therapy for hepatocellular carcinoma: not yet for everybody. Ann Surg Oncol. 2020;27(11):4070-4072. [Invited review]
- Labadie KP, Park JO. Benign Pancreas. SurgOnc SCORE Module. 2019.
- Labadie KP, Park JO. Open and Laparoscopic Hepatectomy. SurgOnc SCORE Module. 2019.
- Labadie KP, Sullivan KM, Park JO. Surgical Resection in HCC. Liver Cancer. 2019